Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor:: An analysis of a series of 42 lymphadenectomies
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor:: An analysis of a series of 42 lymphadenectomies
复制标题
DOI：
10.1016/s1072-7515(02)01250-4
复制
发表时间：
2002-09-01
影响因子：
5.2
通讯作者：
Castaigne, D
中科院分区：
文献类型：
--
作者：
Camatte, S;Morice, P;Castaigne, D
背景技术背景：本研究的目的是评估交界性卵巢肿瘤（BOT）治疗患者淋巴结受累的发生率和临床结局。研究设计：42例患者接受BOT治疗，包括淋巴结切除术。24例患者接受了盆腔淋巴结清扫术，6例接受了主动脉旁淋巴结清扫术，12例接受了两种手术。32例患者进行了系统的淋巴结切除术，5个因为相关的癌症（子宫颈或子宫体）和5个因为笨重的节点发现在手术processed.RESULTS：输卵管内膜炎是在11例（26%）进行淋巴结切除术的患者。8例患者与BOT相关的淋巴结受累。所有淋巴结受累的患者均有浆液性BOT伴腹膜种植体。粘液性肿瘤患者无淋巴结受累。无早期疾病（无腹膜疾病）的患者在常规淋巴结清扫术后发现淋巴结受累。淋巴结转移的患者无一例死于交界性肿瘤。1例患者死于辅助治疗的并发症（化疗后白血病）。结论：卵巢交界性肿瘤和淋巴结受累患者的预后良好。对于早期疾病患者，不应进行常规淋巴结切除术。此手术应在浆液性肿瘤和淋巴结肿大的患者中进行。(C)2002年由美国外科医生学会。
BACKGROUND: The aim of this study is to evaluate the rate and the clinical outcomes of lymph node involvement in patients treated for borderline ovarian tumor (BOT).STUDY DESIGN: Forty-two patients were treated for BOT with a procedure that included lymphadenectomy. Twenty-four patients underwent a pelvic lymphadenectomy, 6 a paraaortic lymphadenectomy, and 12 both procedures. Thirty-two patients underwent systematic lymphadenectomy, five because of associated cancer (uterine cervix or corpus) and five because of bulky nodes discovered during the surgical procedure.RESULTS: An endosalpingiosis was present in 11 (26%) patients who underwent lymphadenectomy. Eight patients bad nodal involvement related to the BOT. All patients with nodal involvement had serous BOT with peritoneal implants. None of the patients with a mucinous tumor had nodal involvement. None of the patients with early-stage disease (without peritoneal disease) had nodal involvement discovered after routine lymphadenectomy. None of the patients with nodal involvement died of borderline tumor. One patient died of a complication of adjuvant therapy (leukemia after chemotherapy).CONCLUSIONS: The prognosis of patients with borderline tumors of the ovary and nodal involvement is excellent. Routine lymphadenectomy should not be performed in patients with early-stage disease. This procedure should be carried out in patients with serous tumor and enlarged lymph nodes. (C) 2002 by the American College of Surgeons.